These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27469086)

  • 21. Hepatitis C treatment in Guatemala: the struggle for access.
    Webster P
    Lancet; 2018 Jul; 392(10144):269-270. PubMed ID: 30064642
    [No Abstract]   [Full Text] [Related]  

  • 22. Single payer. The best option for doctors and patients.
    Wellstone P
    Minn Med; 1994 Sep; 77(9):22-4. PubMed ID: 7968949
    [No Abstract]   [Full Text] [Related]  

  • 23. Time to fix the price fix.
    Earl-Slater A
    Health Serv J; 1997 Nov; 107(5578):22-3. PubMed ID: 10174008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceuticals. Plunder and pillage.
    Earl-Slater A
    Health Serv J; 1999 May; 109(5653):18-20. PubMed ID: 10387802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to HCV treatments: hurdles not barriers.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):1. PubMed ID: 28404005
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C eradication: A long way to go.
    Waheed Y
    World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WHO issues guidelines on HCV amid drug cost controversy.
    Slomski A
    JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
    [No Abstract]   [Full Text] [Related]  

  • 28. Washington Report. Health "reform": Massacre on Capitol Hill.
    Greenberg DS
    N Engl J Med; 1978 Nov; 299(21):1199-200. PubMed ID: 703816
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-31. PubMed ID: 27116794
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-17. PubMed ID: 15724308
    [No Abstract]   [Full Text] [Related]  

  • 31. What does it mean to put new hepatitis C drugs on a list of essential medicines?
    Urrutia J; Porteny T; Daniels N
    BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
    [No Abstract]   [Full Text] [Related]  

  • 32. A better pill to swallow.
    Dhillon S
    Health Serv J; 1993 Mar; 103(5343):30-1. PubMed ID: 10125317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-14. PubMed ID: 12856689
    [No Abstract]   [Full Text] [Related]  

  • 34. Excluding immigrants from primary care brings no savings to NHS, charity claims.
    Moszynski P
    BMJ; 2008 May; 336(7653):1095. PubMed ID: 18483048
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmaceuticals: pharmacy benefit management regulations--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-9. PubMed ID: 16710927
    [No Abstract]   [Full Text] [Related]  

  • 36. Questions hang over European patent for hepatitis C drug after ruling.
    Stafford N
    BMJ; 2016 Oct; 355():i5493. PubMed ID: 27758789
    [No Abstract]   [Full Text] [Related]  

  • 37. Dormant Commerce Clause--Extraterritoriality Doctrine--Fourth Circuit Invalidates Maryland Statute Regulating Price Gouging in the Sale Of Generic Drugs.--Association for Accessible Medicines v. Frosh, 887 F.3d 664 (4th Cir. 2018).
    Harv Law Rev; 2019 Apr; 132(6):1748-55. PubMed ID: 30995706
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmac dogma.
    Douglas B
    N Z Med J; 2007 Feb; 120(1249):U2430. PubMed ID: 17308566
    [No Abstract]   [Full Text] [Related]  

  • 39. Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.
    Gentile I; Maraolo AE; Niola M; Graziano V; Borgia G; Paternoster M
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1227-1234. PubMed ID: 27607920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.